Effectiveness of influenza vaccine in children in day‐care centers of Sapporo
- 18 February 2014
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 56 (1), 53-56
- https://doi.org/10.1111/ped.12221
Abstract
We conducted a retrospective cohort study for evaluating the effectiveness of the trivalent inactivated influenza vaccine (TIV) among children aged 0-6 years in the 2011-2012 season in Sapporo City, Japan, because of scarce evidence. From 10 day-care centers in Sapporo City, Japan, 629 parents participated in the study. Each parent of the subjects described whether a subject received TIV once or twice in the 2011-2012 season, as well as the exact dates of receiving TIV from records in a maternal and child health handbook marked by a pediatrician. The incidence of influenza was defined as being affected with influenza as diagnosed by a pediatrician. Cox's proportional model was used for calculating a hazard ratio (HR) and its 95% confidence interval (95%CI) of TIV on an influenza incidence. After adjusting potential confounding variables, such as the day-care center, presence of comorbidity, size of household, number of siblings, and number of smokers in the home in addition to the age and sex of the child, HR was significantly reduced in the subjects aged 1 year (HR = 0.22, 95%CI 0.09-0.54) as well as in the total subjects (HR = 0.72, 95%CI 0.52-0.99). Consequently, the effectiveness of TIV was calculated as 78% for the subjects aged 1 year and 28% for the total subjects. Our study suggests that TIV is effective, especially in subjects aged 1 year. Further studies are necessary in different seasons, places, and populations to clarify the effectiveness of the influenza vaccine in children.Keywords
This publication has 19 references indexed in Scilit:
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research RoadmapThe Journal of Infectious Diseases, 2010
- Efficacy and Safety of 1 and 2 Doses of Live Attenuated Influenza Vaccine in Vaccine-Naive ChildrenThe Pediatric Infectious Disease Journal, 2009
- Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in AsiaThe Pediatric Infectious Disease Journal, 2007
- Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day CarePEDIATRICS, 2006
- Epidemiology of influenza‐associated encephalitis‐encephalopathy in Hokkaido, the northernmost island of JapanPediatrics International, 2000
- Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineThe Journal of Pediatrics, 2000
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenThe New England Journal of Medicine, 1998
- Comparison of Heterotypic Protection against Influenza A/Taiwan/86 (H1N1) by Attenuated and Inactivated Vaccines to A/Chile/83-like VirusesThe Journal of Infectious Diseases, 1991
- Live Attenuated and Inactivated Influenza Vaccine in School-age ChildrenArchives of Pediatrics & Adolescent Medicine, 1990